Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) P/B ratio
As of 5 November 2026, Neogen Corporation (NEOG) trades at a P/B ratio of 1.2×. Over the past ten years it has ranged from 0.4× (April 2025) to 8.6× (September 2018); the current reading is higher than 26% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2026 | 0.9× | 55.56% |
| FY2025 | 0.6× | (34.19%) |
| FY2024 | 0.9× | (14.09%) |
| FY2023 | 1.1× | (67.18%) |
| FY2022 | 3.2× | (44.46%) |
| FY2021 | 5.8× | 11.05% |
| FY2020 | 5.2× | 13.56% |
| FY2019 | 4.6× | (33.96%) |
| FY2018 | 6.9× | 36.53% |
| FY2017 | 5.1× | 11.26% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Aug 2026 | 1.2× | 30.36% |
| May 2026 | 0.9× | (19.71%) |
| Feb 2026 | 1.2× | 88.78% |
| Nov 2025 | 0.6× | 5.78% |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| NEOG Neogen Corporation | 1.2× |
| INSP Inspire Medical Systems, Inc. compare | 2.3× |
| ITGR Integer Holdings Corporation compare | 2.5× |
| TMDX TransMedics Group, Inc. compare | 4.3× |
| UFPT UFP Technologies, Inc. compare | 5.0× |
| AXGN AxoGen, Inc. compare | 5.4× |
| ALMR Alamar Biosciences, Inc. compare | 6.2× |
| BFLY Butterfly Network, Inc. compare | 8.8× |
| ESTA Establishment Labs Holdings Inc. compare | 89.6× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement